Jeffrey Frankel

764 total citations
17 papers, 521 citations indexed

About

Jeffrey Frankel is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, Jeffrey Frankel has authored 17 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Urology, 11 papers in Rheumatology and 9 papers in Epidemiology. Recurrent topics in Jeffrey Frankel's work include Urinary Bladder and Prostate Research (13 papers), Pelvic floor disorders treatments (11 papers) and Urinary Tract Infections Management (9 papers). Jeffrey Frankel is often cited by papers focused on Urinary Bladder and Prostate Research (13 papers), Pelvic floor disorders treatments (11 papers) and Urinary Tract Infections Management (9 papers). Jeffrey Frankel collaborates with scholars based in United States, Netherlands and Canada. Jeffrey Frankel's co-authors include Rachael Jankowich, Paul N. Mudd, David Staskin, Denise Shortino, Sender Herschorn, Peter T. Scardino, Philip Van Kerrebroeck, Adrie Gunther, Jack Barkin and Montserrat Espuña‐Pons and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and Urology.

In The Last Decade

Jeffrey Frankel

16 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Frankel United States 10 364 315 235 135 95 17 521
Emily E. Cole United States 13 245 0.7× 159 0.5× 50 0.2× 92 0.7× 341 3.6× 18 545
R Fourcade France 7 240 0.7× 123 0.4× 57 0.2× 204 1.5× 31 0.3× 16 325
P C Rasmussen Denmark 7 103 0.3× 20 0.1× 23 0.1× 62 0.5× 308 3.2× 11 414
B. Nadir United States 8 32 0.1× 31 0.1× 26 0.1× 300 2.2× 60 0.6× 13 391
Koen Ackaert Netherlands 8 35 0.1× 78 0.2× 5 0.0× 387 2.9× 71 0.7× 12 434
Kaufman Jj United States 10 122 0.3× 69 0.2× 15 0.1× 126 0.9× 194 2.0× 35 358
Jiyan Yuan China 9 61 0.2× 64 0.2× 12 0.1× 33 0.2× 236 2.5× 13 340
Samuel P. Sterrett United States 11 92 0.3× 30 0.1× 11 0.0× 181 1.3× 133 1.4× 18 326
Başak Erginel Türkiye 10 23 0.1× 19 0.1× 20 0.1× 65 0.5× 211 2.2× 50 310
Toshihide Hayashi Japan 10 7 0.0× 19 0.1× 42 0.2× 68 0.5× 48 0.5× 33 312

Countries citing papers authored by Jeffrey Frankel

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Frankel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Frankel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Frankel more than expected).

Fields of papers citing papers by Jeffrey Frankel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Frankel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Frankel. The network helps show where Jeffrey Frankel may publish in the future.

Co-authorship network of co-authors of Jeffrey Frankel

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Frankel. A scholar is included among the top collaborators of Jeffrey Frankel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Frankel. Jeffrey Frankel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Staskin, David, Jeffrey Frankel, Michael Kennelly, et al.. (2022). Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial. International Journal of Clinical Practice. 2022(1). 6475014–6475014. 10 indexed citations
3.
Frankel, Jeffrey, et al.. (2022). An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder. SHILAP Revista de lepidopterología. 6 indexed citations
4.
Gartrell, Benjamin A., Lawrence I. Karsh, Jeffrey Frankel, et al.. (2022). Concomitant use of oral anticoagulants in patients with advanced prostate cancer receiving apalutamide: A post-hoc analysis of TITAN and SPARTAN studies.. PubMed. 12(1). 445–450. 5 indexed citations
5.
Frankel, Jeffrey, David Staskin, Michael Kennelly, et al.. (2021). Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR. Advances in Therapy. 39(2). 959–970. 8 indexed citations
6.
7.
Staskin, David, Jeffrey Frankel, Michael Kennelly, et al.. (2021). MP63-15 VIBEGRON FOR THE TREATMENT OF PATIENTS WITH DRY OVERACTIVE BLADDER: A SUBGROUP ANALYSIS FROM THE EMPOWUR TRIAL. The Journal of Urology. 206(Supplement 3). 1 indexed citations
8.
Frankel, Jeffrey, et al.. (2020). PD21-01 ONCE-DAILY VIBEGRON 75 MG FOR OVERACTIVE BLADDER (OAB). The Journal of Urology. 203. e453–e453. 2 indexed citations
9.
Frankel, Jeffrey, et al.. (2020). Vibegron improves quality‐of‐life measures in patients with overactive bladder: Patient‐reported outcomes from the EMPOWUR study. International Journal of Clinical Practice. 75(5). e13937–e13937. 16 indexed citations
10.
11.
Frankel, Jeffrey, et al.. (2020). PD21-02 EFFICACY OF ONCE-DAILY VIBEGRON 75 MG FOR OVERACTIVE BLADDER (OAB) IN OLDER PATIENTS. The Journal of Urology. 203. e453–e454. 2 indexed citations
12.
13.
White, William B., Christopher R. Chapple, Christian Gratzke, et al.. (2018). Cardiovascular Safety of the β3‐Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial. The Journal of Clinical Pharmacology. 58(8). 1084–1091. 17 indexed citations
14.
Weber, Michael A., Christopher R. Chapple, Christian Gratzke, et al.. (2018). A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects. Blood Pressure Monitoring. 23(3). 153–163. 10 indexed citations
15.
16.
Scardino, Peter T., Jeffrey Frankel, Thomas M. Wheeler, et al.. (1986). The Prognostic Significance of Post-Irradiation Biopsy Results in Patients with Prostatic Cancer. The Journal of Urology. 135(3). 510–515. 115 indexed citations
17.
Frankel, Jeffrey, et al.. (1985). Condyloma Acuminatum of the Bladder and Associated Urothelial Malignancy. The Journal of Urology. 134(1). 134–136. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily E. Cole Breakdown of academic impact, for papers by R Fourcade Breakdown of academic impact, for papers by P C Rasmussen Breakdown of academic impact, for papers by B. Nadir Breakdown of academic impact, for papers by Koen Ackaert Breakdown of academic impact, for papers by Kaufman Jj Breakdown of academic impact, for papers by Jiyan Yuan Breakdown of academic impact, for papers by Samuel P. Sterrett Breakdown of academic impact, for papers by Başak Erginel Breakdown of academic impact, for papers by Toshihide Hayashi
Rankless by CCL
2026